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Abstract
Background: PROCON was designed to  assess the clinical outcome, development o f adjacent 
disc disease and costs o f cervical anterior discectomy w ithout fusion, w ith fusion using a stand alone 
cage and implantation o f a Bryan's disc prosthesis. Description o f rationale and design o f PROCON 
tria l and discussion o f its strengths and limitations.
Methods/Design: Since p roof justifying the use o f implants o r arthroplasty after cervical anterior 
discectomy is lacking, PROCON was designed. PROCON is a multicenter, randomized controlled 
tria l comparing cervical anterior discectomy w ithou t fusion, w ith fusion w ith a stand alone cage o r 
w ith implantation o f a disc. The study population w ill be enrolled from patients w ith a single level 
cervical disc disease w ithou t myelopathic signs. Each treatment arm w ill need 90 patients. The 
patients w ill be followed fo r a minimum o f five years, w ith visits scheduled at 6 weeks, 3 months, 
12 months, and then yearly. A t one year postoperatively, clinical outcome and self reported 
outcomes w ill be evaluated. A t five years, the development o f adjacent disc disease w ill be 
investigated.
Discussion: The results o f this study w ill contribute to  the discussion whether additional fusion 
o r arthroplasty is needed and cost effective.
T ria l registration: C urrent Controlled Trials ISRCTN41681847
Background
Since the first description of the cervical anterior discec­
tomy with fusion by Cloward and Smith and Robinson in 
1958 respectively in 1955[1,2], and the cervical anterior 
discectomy without fusion in 1960 by Hirsch[3] a debate
is started which of both methods is the best. While this 
discussion is still not closed[4], the advent of the cervical 
disc prosthesis has contributed to extra confusion. Instead 
of two possibilities, nowadays three possible treatments 
concur with each other: cervical anterior discectomy with-
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out implantation of any structure (CAD), cervical anterior 
discectomy with fusion (CADF), and finally, cervical dis­
cectomy with implantation of a disc prosthesis (CADP).
Numerous clinical studies have been published. Several 
prospective, randomized trials have been reported [5-10]. 
However, methodological flaws as non homogenous 
patient population, undefined randomization process, 
small sample sizes, unclear outcome measurements and 
substantial loss of patients for follow -  up, preclude defi­
nite conclusions regarding the efficacy of CAD versus 
CADF.
Recently, the results of a prospectively followed cohort 
have been published. They clearly showed that a cervical 
disc prosthesis is a safe devices[11]. However, one should 
bear in mind that the follow -  up is short.
Several randomized controlled studies comparing arthro­
plasty and fusion with a plate have been reported with 
short follow -  up or are still ongoing. CADF with a plate 
is defined as the gold standard[12,13]. This is very odd, 
since evidence has never been provided that cervical dis- 
cectomy with fusion is better than without[4]. The use of 
a plate is even debatable[14].
Since the costs of implants are enormous, sound clinical 
evidence is needed to justify their use. Therefore, a pro­
spective, randomized trial was developed comparing 
CAD, CADF using a cage, and CADP. Due to the experi­
ence of the principal investigators, the Bryan's disc pros­
thesis was chosen. The design of this trial is described and 
some of its strengths and limitations discussed. It is called 
the PROCON trial referring to the pro's and con's that are 
obvious present for each form of treatment.
Methods/Design  
Study a ims
PROCON has three aims:
1. to conduct a multicentre, randomized controlled trial 
comparing the clinical outcome of the different surgical
T a b le  1: Inc lu s io n  -  and  exc lu s io n  c r i te r ia
options: CAD, CADF using a cage and, finally, CADP with 
implantation of a Bryan's disc prosthesis with a repeated 
longitudinal measurement up to 12 months.
2. to define differences in disc degeneration of the adja­
cent discs between the three surgical options. For this pur­
pose, the patients will be followed for 60 months. All 
intercurrent treatments for cervical disc disease are 
recorded. A magnetic resonance imaging (MRI) scan will 
be performed 60 months after surgery.
3. to estimate the cost-effectiveness of the three surgical 
options.
S tudy sites
The clinical centers that are planned to recruit patients 
into PROCON are located in the Netherlands: University 
Medical Center St. Radboud, Nijmegen; Canisius Wil- 
helmina Hospital, Nijmegen; St. Elisabeth Hospital, 
Tilburg, and finally, De Haaglande Hospital in The Hague.
Study p opu la tio n
To obtain a homogenous patient population the follow­
ing in -  and exclusion criteria will be employed.
Inclusion criteria
All adult patients aged between 18 and 55 years with 
monoradicular signs and symptoms in the arm due to a 
herniated cervical intervertebral disc and/or an osteophyt 
at MRI are eligible for PROCON. The radiological findings 
should be in accordance with the clinical presentation. 
Furthermore, at the preoperative dynamic lateral X -  ray 
the involved level should not have been fused. In -  and 
exclusion criteria are represented in Table 1.
R ec ru itm en t and E n ro llm en t
Participating physicians at each site identify possible can­
didates. After their eligibility is controlled by one of the 
two principal investigators, the patients are informed 
about the PROCON trial. Seven days later, the patients are 
contacted again and informed consent is obtained from 
those willing to participate. Data regarding demographic
In c lu s io n  E xc lu s io n
Age: 18 -  55 years Symptoms and/or signs of myelopathy
Cervical monoradicular symptoms Previous cervical surgery
MRI: herniated cervical intervertebral disc and/or osteophyte in accordance with Psychiatric o r mental disease 
clinical symptoms and signs
Involved level not fused Involvement of liability procedure
Alcoholism (drinking more than 5 units) 
Insufficient of the Dutch language 
Participation in another study 
Two or more levels involved
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characteristics, medical history and comorbidity, signs 
and symptoms, and baseline measurements for all out­
comes are obtained through patient interview, patient 
self-administered survey, and physician survey.
R andom iza tion
For randomisation, the closed envelope method is used. 
As soon as informed consent is obtained, one of the treat­
ment options is assigned to the patient. Prior to surgery, 
the patient is informed about the chosen option. Patients 
who do not choose for participation, are offered one of 
the surgical options that are currently under investigation. 
However, they are not followed in an observational 
cohort study.
Study in te rven tions
Three techniques are subject of study. A standard anterior 
cervical discectomy with the aid of a microscope is used in 
all cases. Whether the approach is from the left or right 
side is up to the preference of the surgeon. In case of CAD, 
the wound is closed after adequate decompression of the 
neural elements. However, if a fusion is chosen a cage 
(cervical I/F, Depuy Acromed, Johnson and Johnson, 
Amersfoort, The Netherlands) filled with bone substitute 
is placed within the intervertebral space. Although a nee­
dle technique for obtaining bone from the iliac crest with 
minimal pain has been described[15], the cage is filled 
with a commercially available bone substitute (beta -  tri­
calcium phosphate) to prevent the pain from the iliac 
crest. The preparation for implantation of the Bryan's disc 
prosthesis (Sofamor Danek, Medtronic, Kerkrade, The 
Netherlands) is done before or after the standard cervical 
discectomy. Of course, the implantation of the prosthesis 
itself follows the discectomy. To prevent calcification 
along the prosthesis, the patients are prescribed meloxi­
cam 15 mg daily for 14 days. The patients within the other 
two groups are prohibited to take non -  steroidal -  anti -  
inflammatory drugs (NSAIDs) for 14 days postopera­
tively.
All patients are encouraged to mobilize as soon as possi­
ble. A collar is never prescribed.
Fo llow  -  up
Follow-up data are gathered at 6 weeks, 3 months and 12 
months. Until 12 months the clinical assessment is done 
by an independent neurologist. Thereafter, the treating 
surgeon will coordinate follow -  up and clinically assess 
the patient. At 12 months a computed tomography (CT) 
is made to evaluate fusion. In the prosthesis group, para­
vertebral calcifications within the long colli muscles can 
be ruled out. From one year until five years postopera­
tively, the patient is seen annually. At each visit plain X 
rays with flexion and extension of the cervical spine are 
made. Questionnaires are also filled out. Sixty months
postoperatively, a MRI study is performed. Sagittal T1, T2 
and proton density images will be obtained to obtain 
information about the adjacent disc.
O utcom es
The primary outcome measure is the clinical and health- 
related quality of life after one year postoperatively as 
measured by both generic and disease specific instru­
ments. Secondary endpoints include work status, fusion 
rate after 1 year, the development of a cervical kyphotic 
deformity at 1 and 5 years, and the incidence of adjacent 
disc disease at 5 years postoperatively.
P rim a ry  outcom es
SF -  36 Health Status Questionnaire is a widely-used 
generic health status. This instrument consists of eight 
subscales and two summary scales. On each scale higher 
scores indicate better outcomes. Scores can be compared 
with published age -  and sex -  matched general popula­
tion or disease-specific norms[16].
The McGill Pain score consists of four parts: 1) a list of 
words to describe the quality and intensity of the pain, 2) 
questions about the effects of the pain on daily life, 3) vis­
ual analogue scales, and 4) questions about the distribu­
tion and course of the pain. The McGill pain score is 
highly effective to measure the effects of a treatment on 
pain[17]. The Dutch version of this score is called the 
MPQ -  DLV: McGill pain questionnaire -  Dutch language 
version[17,18].
Neck Disability Index (NDI)
The NDI is a validated 10 -  item questionnaire, that meas­
ures activity limitations due to neck pain. It is a self -  
reported instrument for the assessment of ADL, and it is a 
revised form of the Oswestry Low Back Pain Index[19,20].
W ork Limitations Questionnaire (WLQ)
The WLQ is a 25 -  item questionnaire developed to meas­
ure health -  related decrements in ability to perform job 
roles among employed individuals. Patients themselves 
fill in the questionnaire. The WLQ scale scores have been 
proven to be sensitive to changes in health status over 
time [21].
Secondary outcom es
The impact of surgery on working status is evaluated by 
calculating the duration before the patients fully resume 
normal activities. We will also document whether the 
patients are capable returning to their original jobs or if 
they have to change their work. The work limitations 
questionnaire is used to obtain a score that reflects the 
amount of discomfort the patient have performing their 
job. The pre-intervention scores are the baseline for follow
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-  up. The mean differences are compared between the 
treatment arms.
Radiologic examinations are performed preoperatively 
and at each follow -  up visit. At one year, a radiologist 
evaluates whether there is fusion on CT and plain X-Ray. 
The angle between the adjacent vertebrae is measured 
when the patient is holding the neck in neutral position 
while sitting. The angle between the endplate of the sec­
ond cervical vertebral body and the upper endplate of the 
seventh cervical vertebra is also determined. Furthermore, 
this is also done when the patient maximally flexes or 
extends the neck. At five years postoperatively, the same 
evaluation is done. The development of anterior osteo­
phytes of decrease of disc height of the adjacent levels is 
noted. Changes in time are determined within each treat­
ment arm. The mean values are also compared between 
each treatment arm at 1 year and 5 year follow -  up. 
Finally, at five years follow -  up a MRI is made to evaluate 
whether a change of the quality of the intervertebral discs 
of the adjacent level can be shown.
Cost -  effectiveness
The aim of cost -  effectiveness analysis is to reveal how 
differences in clinical outcome between the three surgical 
techniques relate to differences in their resource require­
ments. To this end, volumes of major cost drivers such as 
hospitalisation, medication use, out -  patients consulta­
tions etcetera will be registered for each individual. For 
cost prices, national guidelines will be used. If differences 
are observed between the groups in resumption of work, 
costs of lost productivity will be estimated using the fric­
tion -  cost method. Incremental cost -  effectiveness ratios 
will be calculated: uncertainty of these estimates will be 
determined using bootstrap techniques[22].
M o n ito re d  events
Monitored events are the death of a patient, withdrawal 
from the study, lost to follow -  up, and cross -  over from 
their randomly assigned treatment group. These events are 
registered within the case record form. The circumstances 
of the events are investigated and also noted. In case of 
death of the patient, a search for a relationship with the 
instituted treatment is started. Throughout the study, all 
medical complications and intervening treatments con­
cerning the cervical spine are registered within the CRF at 
the usual follow -  up visits or when the appropriate infor­
mation reaches the treating surgeon.
P ro toco l v io la tio n s
Any of the following will be considered as a deviation 
from the protocol: randomization of an ineligible patient, 
enrollment of a patient that is already participating in an 
another study, enrollment of an PROCON participant in 
another study, a patient receiving the wrong treatment,
loss of radiology or any other data, and informed consent 
violations. Violations are reviewed biweekly and reported 
to the independent study supervisor.
S ta tis tic a l Analysis
Our primary analysis is based on the intention to treat 
principle.
The primary study endpoints will be measured as changes 
from pre-intervention baseline scores. The mean scores of 
the three treatment arms will be compared at each follow- 
up time.
Sample size calculations were based on the outcome 
reported in literature. An excellent outcome (no com­
plaints at all) is generally achieved in 60% of the patients, 
that underwent CAD or CADF. An increase of 20% was 
found acceptable to justify the use of a prosthesis.
With a power of 80 % and a two -  sided level of signifi­
cance of 0.05, a chi-square analysis would need 81 
patients per group. Assuming a loss to follow -  up of 10 
%, a total of 270 patients are needed.
No subgroup analyses are planned, nor any interim -  
analyses.
O rgan iza tion  o f  th e  study
The coordinating center of the study is located at the Can- 
isius Wilhelmina Hospital, Nijmegen, The Netherlands, 
and at the University Medical Center Nijmegen St. Rad­
boud. Technically, four groups exist within the organiza­
tion. The first one is the trial direction, consisting of the 
leading investigators who also enroll patients in the study. 
They coordinate activities and liaise with other participat­
ing studies. The second one is the group of independent 
neurologists and radiologists. They are not involved in the 
coordination of the study. The third group is the medical 
technology assessment. They are involved in the develop­
ment of the study protocol. They also control the input of 
data and perform statistical analysis of the data. The 
fourth and last group, is the independent supervising phy­
sician. He is a neurologist without experience in spine 
pathology. He does not examine patients for the study. 
Violations against the protocol are reported to him. He is 
also the contact person for those patients that have com­
plaints not related to their disease or treatment (e.g. about 
the doctor). Patients can also contact him if they have 
questions during the study, about the study or are in 
doubt whether or not to participate.
Discussion
Despite the lack of evidence in favour of one of the possi­
ble procedures, during the last decade the number of 
fusions has increased dramatically in the United States,
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whereas the total number of cervical spine procedures 
remained relatively constant[23]. The costs of fusion are 
considerable. In the Netherlands, a plate costs about 500 
euro's and a cage about 700 euro's. The price of a disc 
prosthesis is even higher, about 2500 euro's. In the United 
States, disc prostheses are booming business. It is esti­
mated that the market could approach $1.7 billion a year 
by 2010[24].
Apart from the clinical effectiveness, it is obvious that 
studies are needed to justify the enormous costs of fusion 
or arthroplasty. Several studies are conducted comparing 
arthroplasty with fusion. The design of this study is 
unique, since it does add an extra treatment arm, cervical 
anterior discectomy without fusion.
Several problems may arise. Randomization may not be 
easily accepted by patients. However, from a previous ran­
domized controlled trial comparing surgical tech- 
niques[25], we learned that correct description of 
possibilities and estimated outcomes patients are not 
reluctant to participate. Especially the fact that no proof 
exists for one or another treatment will increase accept­
ance.
Surgery may have a placebo effect[26]. Clinical objective 
outcome is measured, but also self reported outcomes. 
PROCON is not able to determine a possible placebo 
effect. Although it must be considered a limitation of the 
study, its clinical value should also be questioned.
External validity and generalizability is often discussed. 
Patient selection is restricted to one level cervical disease 
without myelopathy. Therefore, the results cannot be 
extrapolated to two or more level disease, nor to patients 
with myelopathic symptoms and signs. On the other 
hand, the restriction to one level disease does prevent the 
need for stratification and loss of power during statistical 
analysis.
Although surgical skill may differ, a microscopic cervical 
anterior discectomy is a rather standard and straightfor­
ward technique. The use of the same implants does not 
allow variation due to construct design. Therefore, we do 
not feel that variation in skill will seriously affect the out­
come of the study.
The second part of PROCON is the radiological evalua­
tion of the development of adjacent disc disease. The pre­
intervention plain X Rays are used as baseline study. The 
development of osteophytes or the increase of existing 
osteophytes may be a measure for the progression of adja­
cent disc disease. At five years postoperatively, an MRI is 
made to judge the quality of the adjacent discs. The ques­
tion raises whether this time is long enough. At five years,
adjacent disc disease may not have been fully developed, 
and perhaps its prevalence is not high enough to be statis­
tically significant. However, extension of follow up time 
would severely compromise the inclusion of patients, and 
would also induce a high number of loss to follow up.
Finally, PROCON does measure costs. It is questionable if 
these findings can be extrapolated to other countries. First, 
the fee for hospitals and doctors are different. Secondly 
and probably most importantly, the compensation for 
sick leave is very differently arranged compared to other 
countries. Patients feel less urge to resume their daily 
working activities[27]. Therefore, the external validity of 
results of the cost effectiveness or cost minimization study 
will be extremely low, although tendencies might be for­
mulated.
Conclusion
Cervical anterior discectomy is frequently performed. The 
need for a randomized controlled trial comparing the cer­
vical discectomy without fusion, with fusion and the 
newer technique arthroplasty is obvious. The costs of 
implants are enormous, whereas their effectiveness has 
never been proved. The design of such a study, and some 
of its limitations are discussed.
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